Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
7,720 results in Europe PMC
PubMed plus preprints and full-text open access papers. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Phase 2 Trial of Icotrokinra for Patients with Ulcerative Colitis.
Abreu MT, Siegmund B, Surace L, Erondu N, Chen M, Chachu K, Louis E, Matsuoka K, Limdi J, Arthur E, Houck N, Marano C, Vetter ML, Zou B, Zhan J, Frustaci ME, Kannan AK, Rydzewska G, Loftus EV, Jairath V, ANTHEM-UC Study Group. · N Engl J Med · 2026 · cited 2 timesclinical trial, phase ii, multicenter study
- Clinical significance of isolated periappendiceal red patch in ulcerative colitis: A systematic review, meta-analysis, and meta-regression.
Abdul Rehman K, Us Sehar N, Akram U, Fatima E, Ahsan S, Ahmed SZ, Faizan A, Javid S, Hassan SA, Berinstein JA, Barrett TA. · Inflamm Bowel Dis · 2026 · cited 0 timesmeta-analysis, systematic review
- Stratified by baseline corticosteroid use: which advanced therapy works best for whom in ulcerative colitis?
Dong M, Li Z, Hua H, Ma Q, Xu X, Wu J. · Front Med (Lausanne) · cited 0 timesOpen accesssystematic-review, review
- Multidimensional Deciphering Underlying Effects of PFOA Exposure in Ulcerative Colitis: From Epidemiological Insights to Toxicological Mechanisms.
Zhang H, Liu Y, Zhao Y, Li W, Han Y, Liu J, Wang H, Wang Z, He Z, Bai Y. · Chem Res Toxicol · 2026 · cited 0 timesmeta-analysis
- Hierarchical benefit of multidimensional remission in ulcerative colitis: a systematic review and meta-analysis.
Zhang J, Zhong S, Ma M, Lin Z, Ma Y, Padungkiettiwong W, Lin C, Yuan CS, Koh M, Tan HY, Bian Z. · BMC Gastroenterol · 2026 · cited 0 timesmeta-analysis, im
- Design and outcome measures of clinical trials for active ulcerative colitis: a scoping review based on databases.
Zhao X, Feng C, Zhao C, Zhang R, Zhang S, Wang R, Guo J, Yan C, Chen L. · Front Immunol · 2026 · cited 0 timesOpen accessscoping review, systematic-review
- Dual therapy with tofacitinib and steroids for acute severe ulcerative colitis: a randomized double-blind placebo-controlled trial.
Arora U, Verma M, Madan D, Singh M, Kandasamy D, Narang H, Goyal M, Mahajan M, Mundhra SK, Prasad S, Mubunnu M, Goyal A, Panwar R, Sehgal T, Dash NR, Sharma R, Bhardwaj V, Kedia S, Makharia G, Ahuja V. · J Crohns Colitis · 2026 · cited 0 timesrandomized controlled trial
- Stratified by baseline corticosteroid use: which advanced therapy works best for whom in ulcerative colitis?
Dong M, Li Z, Hua H, Ma Q, Xu X, Wu J. · Front Med (Lausanne) · 2026 · cited 0 timessystematic review
- Probiotics Accelerate Microbiota and Metabolic Pathway Recovery Following Colonoscopy Bowel Preparation in Ulcerative Colitis.
Ma X, Guan J, Liu G, Tian B, Tong C, Chen X. · Med Sci Monit · 2026 · cited 0 timesOpen accessrandomized controlled trial
- Pharmacological treatments for moderate-to-severe ulcerative colitis: a systematic review and Bayesian network meta-analysis.
Qi J, Tian Q, Yang G, Chen Z. · Scand J Gastroenterol · 2026 · cited 0 timessystematic review, network meta-analysis
- Tofacitinib 20 vs 30 mg in acute severe ulcerative colitis: a double-blind randomized controlled trial.
Singh A, Garg A, Bhardwaj A, Singh D, Thakur A, Kaur L, Singla A, Kapoor L, Mahajan R, Mehta V, Goyal O, Gupta YK, Sharma N, Midha V, Sood A. · J Crohns Colitis · 2026 · cited 0 timescomparative study, randomized controlled trial
- Risk Factors for Pouchitis After Ileal Pouch-Anal Anastomosis in Ulcerative Colitis Patients.
Du H, Xiao W, Yin W, Yang X, Fan X, Li B, He A, Yu Q, Liu G. · Turk J Gastroenterol · 2026 · cited 0 timessystematic review
- Sodium Butyrate Therapy in Ulcerative Colitis: A Systematic Review of Preclinical and Clinical Evidence.
Golea GI, Ilieș RA, Caziuc A, Andraș D, Ilie-Ene A, Seicean R, Neagoe RM, Dăscălescu Ș, Simionescu L, Vesa ȘC, Dindelegan GC, Zaharie F. · Med Sci (Basel) · 2026 · cited 0 timesOpen accesssystematic review, review-article
- Benefit-risk profiling of advanced therapies in moderate-to-severe ulcerative colitis: a clustered network meta-analysis.
Zhang X, Qian H, Yang L, Wang H, Sun G, Lin A. · Front Pharmacol · 2026 · cited 0 timesOpen accesssystematic review, systematic-review
- S1P receptor modulators for moderate-to-severe ulcerative colitis: a systematic review, meta-analysis, and trial sequential analysis.
Jomaa A, Bshara R, Alani M, Ismail B, Rajab Y, Hayder D, Abozait HJ, Jomaa W, Neda W, Najim M, Al-Obaidi H. · J Gastroenterol · 2026 · cited 0 timesmeta-analysis, systematic review
- Rethinking the dose: A Bayesian meta-analysis of infliximab intensification in acute severe ulcerative colitis.
Goyal MK, Dutta P, Choy MC, Berinstein JA, Hassan SA, Sharma V, Ahuja V, Berinstein E, Li Wai Suen CFD, Higgins PDR, Con D, Cruz P, Bishu S. · Inflamm Bowel Dis · 2026 · cited 0 timesmeta-analysis
- 2'-Fucosyllactose modulates gut microbiota and systemic metabolism in mild-to-moderate ulcerative colitis: a randomized crossover trial.
Kennedy JM, De Silva AN, Morales PS, Poveda Turrado CG, Walton GE, Gibson GR. · J Crohns Colitis · 2026 · cited 0 timesOpen accessrandomized controlled trial
- Safety and efficacy of etrasimod in ulcerative colitis: Evidence from a meta-analysis.
Alla D, Appala S, Meyur S, Ganguru SL, Ramsundar R, Gupta S, Sriramaneni PK, Boppana G, Cheguru SR, Emmanuel NW, Bolineni M, Rohan RP, Chowdhary R. · Medicine (Baltimore) · 2026 · cited 0 timesOpen accessmeta-analysis
- A meta-analysis of the efficacy and safety of Janus kinase inhibitors in patients with ulcerative colitis.
Yang Q, Yan Y. · Medicine (Baltimore) · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Sialidase inhibitor modulates gut microbiota and enhances mucosal protection in the treatment of ulcerative colitis.
Zhao Y, Chen L, Li C, Xu Y, Huang J, Chen S, Yu Z, Liu X. · mSystems · 2026 · cited 1 timesOpen accessrandomized controlled trial
- Comparative efficacy of dietary interventions and enteral nutrition in adults with ulcerative colitis: a network meta-analysis.
Wang T, Ji L, Sun C, Liu H, Li J, Hong Y. · Front Nutr · 2026 · cited 0 timesOpen accesssystematic review, systematic-review
- A systematic review and meta-analysis of acupuncture for intestinal protection and underlying mechanisms in animal models of ulcerative colitis.
Zhang J, Zheng X, Zuo G, Wang Y, Zheng X, Sun Y, She Y. · Medicine (Baltimore) · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Gut microbiota dysbiosis in the pathogenesis of ulcerative colitis and the therapeutic efficacy of fecal microbiota transplantation: a meta-analysis.
Zhu C, Wang M, Meng L, Zhao Z, Han H, Chang Y, Zhang S, Yang Y. · BMC Gastroenterol · 2026 · cited 0 timesOpen accessmeta-analysis, review-article
- Efficacy and safety of duvakitug in patients with ulcerative colitis (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial.
Reinisch W, Stepek D, Kempinski R, Danese S, Sands BE, Ratiu-Duma B, Singh R, Levine P, Barkay H, Gross N, Abrams K, Jairath V. · Lancet Gastroenterol Hepatol · 2026 · cited 6 timesclinical trial, phase ii, research support, non-u.s. gov't
- Rapid symptomatic improvement with etrasimod in ulcerative colitis: a post-hoc analysis of the ELEVATE UC program.
Dubinsky MC, Chaparro M, Irving PM, Hur P, Sidhu S, Woolcott JC, Wang W, Goetsch M, Torres J, Panaccione R. · Inflamm Bowel Dis · 2026 · cited 1 timesOpen accessclinical trial, phase iii, randomized controlled trial
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.